Victrelis (boceprevir) Labeling Update
On November 2, 2012, the Victrelis (boceprevir)
package insert and Medication Guide was updated to include postmarketing information about serious acute hypersensitivity reactions observed during boceprevir, peginterferon, and ribavirin combination therapy. The following sections of the package insert were updated.
A new contraindication was added to section 4:
Patients with a history of a hypersensitivity reaction to boceprevir
Section 5.